Australia: Discover the neuropsychological effects of HIV and assessment strategies in this professional development course. Understand HAND and treatment.
Australian psychologists working in health, neuropsychology or community settings can use this course to understand how HIV affects the brain. Clinical neuropsychologist Digby Ormond-Brown introduces the epidemiology and pathophysiology of the virus, then explains the diagnostic criteria for HIV-Associated Neurocognitive Disorder across its range of severity. He describes how HAND is identified with neuropsychological assessment tools and considers biomarkers and the potentially neuroprotective role of antiretroviral treatment, helping clinicians recognise and understand the cognitive implications of HIV for the clients they see.
This specialised talk , presented by experienced Clinical Neuropsychologist Digby Ormond-Brown, explores the neuropsychological impact of HIV, with a particular focus on HIV’s effects on brain function and cognition. The session begins with a concise overview of HIV pathophysiology, highlighting how the virus affects neurological structures.
Participants will gain a clear understanding of HIV-Associated Neurocognitive Disorder (HAND), including the spectrum of severity from asymptomatic neurocognitive impairment to HIV-associated dementia. Digby also outlines how HAND is identified and measured through neuropsychological assessment tools, and examines the role of biomarkers and the potential neuroprotective effects of antiretroviral treatment.
This talk is ideal for psychologists working in health, neuropsychology, or community settings who want to increase their confidence in identifying and understanding the cognitive implications of HIV.
Sections
Learning Outcomes
By the end of this talk, participants will be able to:
Describe how HIV affects the brain and cognition.
Understand the diagnostic criteria for HIV-Associated Neurocognitive Disorder (HAND).
Identify appropriate neuropsychological assessment methods for HAND.
Interpret the relevance of biomarkers in cognitive impairment related to HIV.
Consider the cognitive and neurological impact of antiretroviral therapy.